1. A rare case of Blastomyces dermatitidis brain abscess in an immunocompetent host
   Magdalena Slomka et al, 2020, Medical Mycology Case Reports CrossRef
2. Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High‐Complexity Hospital
   Maria Clara Padovani de Souza et al, 2016, The Journal of Clinical Pharmacology CrossRef
3. Persistent dyselectrolytemia in a neonate induced by liposomal amphotericin B. A case report
   Adrian Puertas Sanjuan et al, 2023, Frontiers in Pediatrics CrossRef
4. Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria
   Fatma Devrim et al, 2021, Néphrologie & Thérapeutique CrossRef
5. Rhodotorula mucilaginosa Fungemia, a Rare Opportunistic Infection without Central Venous Catheter Implantation, Successfully Treated by Liposomal Amphotericin B
   Ryuichi Hirano et al, 2022, Case Reports in Infectious Diseases CrossRef
6. Empirical vs pre-emptive broad-spectrum antifungal therapy for acute myelogenous leukaemia in the era of antimould prophylaxis
   Sang-Min Oh et al, 2023, International Journal of Antimicrobial Agents CrossRef
7. Hypokalemic paralysis following intramuscular betamethasone injection: A case report and review of literature
   Pouya Ebrahimi et al, 2024, Clinical Case Reports CrossRef
8. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study
   Yuki Ota et al, 2021, BMC Nephrology CrossRef
9. Analysis of Hypokalemia as a Side Effect of Liposomal Amphotericin in Pediatric Patients
   Ryoji Kobayashi et al, 2018, Pediatric Infectious Disease Journal CrossRef
10. Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
    Riccardo Giampieri et al, 2020, Oncology and Therapy CrossRef
11. Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study
    Naoto Okada et al, 2018, Clinical Therapeutics CrossRef
12. The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
    José Ramón Azanza et al, 2021, Mycoses CrossRef
13. Tolerability profile of the current antifungal armoury
    Ahmad Mourad et al, 2018, Journal of Antimicrobial Chemotherapy CrossRef